These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22522849)

  • 61. Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series.
    Staines K; Hampton PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):e49-56. PubMed ID: 22727107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy.
    Ma L; You C; Hernandez M; Maleki A; Lasave A; Schmidt A; Stephenson A; Zhao T; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2019; 27(4):636-642. PubMed ID: 29517945
    [No Abstract]   [Full Text] [Related]  

  • 63. [Cicatricial pemphigoid: treatment with mycophenolate mofetil].
    Ingen-Housz-Oro S; Prost-Squarcioni C; Pascal F; Doan S; Brette MD; Bachelez H; Dubertret L
    Ann Dermatol Venereol; 2005 Jan; 132(1):13-6. PubMed ID: 15746600
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pure ocular cicatricial pemphigoid. A distinct immunopathologic subset of cicatricial pemphigoid.
    Hoang-Xuan T; Robin H; Demers PE; Heller M; Toutblanc M; Dubertret L; Prost C
    Ophthalmology; 1999 Feb; 106(2):355-61. PubMed ID: 9951490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 66. [Cicatricial pemphigoid--an important differential diagnosis in inflammatory mucous membrane changes].
    Baier G; Zillikens D
    Laryngorhinootologie; 1999 Nov; 78(11):632-7. PubMed ID: 10615658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dapsone therapy for the acute inflammatory phase of ocular pemphigoid.
    Fern AI; Jay JL; Young H; MacKie R
    Br J Ophthalmol; 1992 Jun; 76(6):332-5. PubMed ID: 1622942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cicatricial pemphigoid.
    Ahmed AR; Kurgis BS; Rogers RS
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):987-1001. PubMed ID: 1869688
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
    Sami N; Bhol KC; Razzaque Ahmed A
    Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The immunological features and pathophysiology of ocular cicatricial pemphigoid.
    Elder MJ; Lightman S
    Eye (Lond); 1994; 8 ( Pt 2)():196-9. PubMed ID: 7958021
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches.
    Sacher C; Hunzelmann N
    Am J Clin Dermatol; 2005; 6(2):93-103. PubMed ID: 15799681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
    Galdos M; Etxebarría J
    Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cicatricial pemphigoid (benign mucous membrane pemphigoid).
    Terezhalmy GT; Bergfeld WF
    Quintessence Int; 1998 Jul; 29(7):429-37. PubMed ID: 9759059
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
    Munyangango EM; Le Roux-Villet C; Doan S; Pascal F; Soued I; Alexandre M; Heller M; Lièvre N; Aucouturier F; Caux F; Laroche L; Prost-Squarcioni C
    Br J Dermatol; 2013 Feb; 168(2):381-90. PubMed ID: 22963186
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.
    Kennedy JS; Devillez RL; Henning JS
    J Drugs Dermatol; 2010 Jan; 9(1):68-70. PubMed ID: 20120429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid.
    Foster CS; Neumann R; Tauber J
    Doc Ophthalmol; 1992; 82(3):223-9. PubMed ID: 1303858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Syngeneic transplantation of nasal mucosa and azathioprine medication for therapy of cicatricial ocular mucous membrane pemphigoid. Study of 9 patients with 11 eyes].
    Bialasiewicz AA; Förster W; Radig H; Hüttenbrink KB; Grewe S; Busse H
    Ophthalmologe; 1994 Apr; 91(2):244-50. PubMed ID: 8012145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS; Meyerhoff WE; Cohen SB
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.